Herzog Eyal, Shapiro Janet, Aziz Emad F, Chong Ji, Hong Mun K, Wiener Dan, Lee Richard, Janis Gregory, Azrieli Yevgeny, Velazquez Barbara, Lacdao Leonida, Mittal Suneet
Division of Cardiology, St. Luke's-Roosevelt Hospital Center, College of Physicians and Surgeons, Columbia University, New York, NY 10025, USA.
Crit Pathw Cardiol. 2010 Jun;9(2):49-54. doi: 10.1097/HPC.0b013e3181dc4d14.
The estimated number of out-of-hospital care arrest cases is about 300,000 per year in the United States. Two landmark studies published in 2002 demonstrated that the use of therapeutic hypothermia after cardiac arrest decreased mortality and improved neurologic outcome. Based on these studies, the International Liaison Committee on Resuscitation and the American Heart Association recommended the use of therapeutic hypothermia after cardiac arrest. Therapeutic hypothermia is defined as a controlled lowering of core body temperature to 32 degrees C to 34 degrees C. This temperature goal represents the optimal balance between clinical effect and cardiovascular toxicity. Therapeutic hypothermia does require resources to implement-including device, close nursing care, and monitoring. It is important to select patients who have potential for benefit from this technique which is a limited resource and carries potential complications. A collaborative team approach involving physicians and nurses is critical for successful development and implementation of this kind of a protocol. In 2004, the "Advanced Cardiac Admission Program" was launched at the St. Luke's Roosevelt Hospital Center of Columbia University in New York. The program consists of a series of projects, which have been developed to bridge the gap between published guidelines and implementation during "real world" patient care. In this article, we are reporting our latest project for the comprehensive management of survivors of out-of-hospital cardiac arrest. The pathway is divided into 3 steps: Step I, From the field through the emergency department into the cardiac catherization laboratory and to the critical care unit; Step II, Induced invasive hypothermia protocol in the critical care unit (this step is divided into 3 phases: 1, invasive cooling for the first 24 hours; 2, rewarming; 3, maintenance); Step III, Management post the rewarming phase including the recommendation for out-of-hospital therapy and the ethical decision to define goal of care. We hope that this novel pathway will bridge the gap between the complex guidelines and the actual clinical practice and will improve the survival and neurologic condition of patients suffering cardiac arrest.
在美国,每年院外心脏骤停病例的估计数量约为30万例。2002年发表的两项具有里程碑意义的研究表明,心脏骤停后使用治疗性低温可降低死亡率并改善神经学转归。基于这些研究,国际复苏联合委员会和美国心脏协会建议在心脏骤停后使用治疗性低温。治疗性低温定义为将核心体温控制性降低至32摄氏度至34摄氏度。该温度目标代表了临床效果与心血管毒性之间的最佳平衡。治疗性低温确实需要资源来实施,包括设备、密切的护理和监测。选择有可能从这种技术中获益的患者很重要,因为这是一种有限的资源且存在潜在并发症。涉及医生和护士的协作团队方法对于成功制定和实施此类方案至关重要。2004年,纽约哥伦比亚大学圣卢克罗斯福医院中心启动了“高级心脏入院项目”。该项目由一系列项目组成,旨在弥合已发表指南与“现实世界”患者护理期间的实施之间的差距。在本文中,我们报告了我们关于院外心脏骤停幸存者综合管理的最新项目。该路径分为3个步骤:第一步,从现场经急诊科进入心导管实验室再到重症监护病房;第二步,在重症监护病房进行诱导性有创低温方案(此步骤分为3个阶段:1,最初24小时的有创降温;2,复温;3,维持);第三步,复温阶段后的管理,包括院外治疗建议和确定护理目标的伦理决策。我们希望这条新颖的路径将弥合复杂指南与实际临床实践之间的差距,并改善心脏骤停患者的生存率和神经状况。